Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo, Curr Protoc Mol Biol, vol.69, 2005. ,
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells, Mol Oncol, vol.10, pp.73-84, 2016. ,
The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease, Cell Metab, vol.16, pp.290-295, 2012. ,
Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP, FEBS Lett, vol.537, pp.157-160, 2003. ,
FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973, EJNMMI Res, vol.2, p.22, 2012. ,
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes, J Cell Biol, vol.142, pp.827-835, 1998. ,
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, pp.94-98, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01791271
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells, J Biol Chem, vol.287, pp.29887-29898, 2012. ,
NAD + metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus, Cell Metab, vol.22, pp.31-53, 2015. ,
A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma, Cancer Cell, vol.24, pp.466-480, 2013. ,
PARP1 orchestrates epigenetic events setting up chromatin domains, Semin Cell Dev Biol, vol.63, pp.123-134, 2017. ,
Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor, Oncotarget, vol.4, pp.1986-1998, 2013. ,
The BRAF inhibitor vemurafenib activates mitochondrial metabolism and inhibits hyperpolarized pyruvate-lactate exchange in BRAF-mutant human melanoma cells, Mol Cancer Ther, vol.15, pp.2987-2999, 2016. ,
Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems, Anal Chem, vol.81, pp.6656-6667, 2009. ,
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma, Genes Dev, vol.31, pp.18-33, 2017. ,
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma, Pigment Cell Melanoma Res, vol.28, pp.718-729, 2015. ,
,
, Oncogenic BRAF regulates oxidative metabolism via PGC1? and MITF, Cancer Cell, vol.23, pp.302-315
STAT5 contributes to antiapoptosis in melanoma, Melanoma Res, vol.18, pp.378-385, 2008. ,
Simple combinations of lineage-determining transcription factors prime cisregulatory elements required for macrophage and B cell identities, Mol Cell, vol.38, pp.576-589, 2010. ,
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X L , and survivin, J Invest Dermatol, vol.128, pp.1499-1505, 2008. ,
In vivo switching of human melanoma cells between proliferative and invasive states, Cancer Res, vol.68, pp.650-656, 2008. ,
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor, Invest New Drugs, vol.26, pp.45-51, 2008. ,
Sirtuins as regulators of metabolism and healthspan, Nat Rev Mol Cell Biol, vol.13, pp.225-238, 2012. ,
Non-genomic and immune evolution of melanoma acquiring MAPKi resistance, Cell, vol.162, pp.1271-1285, 2015. ,
Sirtuins in epigenetic regulation, Chem Rev, vol.115, pp.2350-2375, 2015. ,
Melanoma driver mutations and immune therapy, Oncoimmunology, vol.5, p.1051299, 2016. ,
NAD + salvage pathway in cancer metabolism and therapy, Pharmacol Res, vol.114, pp.274-283, 2016. ,
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells, Elife, vol.4, p.6857, 2015. ,
Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, vol.25, pp.1754-1760, 2009. ,
CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression, Mol Cell Biol, vol.31, pp.955-970, 2011. ,
Targeted agents and immunotherapies: optimizing outcomes in melanoma, Nat Rev Clin Oncol, vol.14, pp.463-482, 2017. ,
MEK1/2 induces STAT5-mediated germline transcription of the TCR? locus in response to IL-7R signaling, J Immunol, vol.181, pp.494-502, 2008. ,
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions, Pigment Cell Melanoma Res, vol.26, pp.144-146, 2013. ,
Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism, J Inherit Metab Dis, vol.38, pp.1029-1039, 2015. ,
STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases, J Invest Dermatol, vol.126, pp.2272-2280, 2006. ,
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma, Nat Commun, vol.5, p.5712, 2014. ,
Senescent cells develop a PARP-1 and nuclear factor-?B-associated secretome (PNAS), Genes Dev, vol.25, pp.1245-1261, 2011. ,
SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells, Oncotarget, vol.5, pp.2085-2095, 2014. ,
Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation, Mol Cell Biol, vol.18, pp.3871-3879, 1998. ,
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis, Cancer Discov, vol.4, pp.423-433, 2014. ,
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study, Eur J Cancer, vol.41, pp.702-707, 2005. ,
CtBP and associated LSD1 are required for transcriptional activation by NeuroD1 in gastrointestinal endocrine cells, Mol Cell Biol, vol.34, pp.2308-2317, 2014. ,
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment, Nat Commun, vol.6, p.8755, 2015. ,
PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation, PLoS Genet, vol.9, p.1003531, 2013. ,
The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants, Am J Respir Cell Mol Biol, vol.51, pp.660-667, 2014. ,
Extreme vulnerability of IDH1 mutant cancers to NAD + depletion, Cancer Cell, vol.28, pp.773-784, 2015. ,
STAT5 is critical to maintain effector CD8 + T cell responses, J Immunol, vol.185, pp.2116-2124, 2010. ,
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state, Nat Commun, vol.6, p.6683, 2015. ,
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data, Cancer Chemother Pharmacol, vol.65, pp.1165-1172, 2010. ,
Noninvasive genomic detection of melanoma, Br J Dermatol, vol.164, pp.797-806, 2011. ,
On the origin of cancer cells, Science, vol.123, pp.309-314, 1956. ,
Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate, Cancer Cell, vol.21, pp.297-308, 2012. ,
seqMINER: an integrated ChIP-seq data interpretation platform, Nucleic Acids Res, vol.39, p.35, 2011. ,
Model-based analysis of ChIP-seq (MACS), Genome Biol, vol.9, 2008. ,
, six months after the full-issue publication date, Creative Commons License (Attribution-NonCommercial 4.0 International), as described )